Tricitrates Solution
NDC Package 0121-0677-16
Package Information
Tricitrates (potassium citrate, sodium citrate, and citric acid monohydrate) solution is a medication used to make the urine less acidic. This formulation utilizes a solution delivery system. Marketed by Pai Holdings, Llc Dba Pai Pharma, this product is identified by NDC 0121-0677.
Identification & Billing
- RxCUI: 309317 - citric acid 334 MG / potassium citrate 550 MG / sodium citrate 500 MG in 5 mL Oral Solution
- RxCUI: 309317 - citric acid 66.8 MG/ML / potassium citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
- RxCUI: 309317 - citric acid 334 MG / potassium citrate 550 MG / sodium citrate 500 MG per 5 ML Oral Solution
- RxCUI: 309317 - Citric Acid 66.8 MG/ML / K+ citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
- RxCUI: 309317 - Citric Acid 66.8 MG/ML / Pot citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
Clinical Specifications
- Acidifying Activity - [MoA] (Mechanism of Action)
- Acidifying Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0121 - Pai Holdings, Llc Dba Pai Pharma
- 0121-0677 - Tricitrates
- 0121-0677-16 - 473 mL in 1 BOTTLE
- 0121-0677 - Tricitrates
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0121-0677-16 identifies a specific commercial package of 473 ml in 1 bottle of Tricitrates, a human prescription drug labeled by Pai Holdings, Llc Dba Pai Pharma. This solution is formulated for oral use and contains citric acid monohydrate; potassium citrate; sodium citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pai Holdings, Llc Dba Pai Pharma on May 25, 2005. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to make the urine less acidic. Urine that is less acidic helps the kidneys get rid of uric acid, helping to prevent gout and certain types of kidney stones (urate). This medication can also prevent and treat certain metabolic problems (acidosis) caused by kidney disease. Citric acid and citrate salts (which contain potassium and sodium) belong to a class of drugs known as urinary alkalinizers. Because some conditions require you to limit your intake of potassium and sodium, your doctor's choice of product may depend on how much potassium and sodium you can take.
How is this Pai Holdings, Llc Dba Pai Pharma product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00121067716. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.